Back to the main directory
Company Analysis / Equity
- NextEra's Renewable Energy Business Big Beneficiary of Tax Reform, Boosting Outlook by Morningstar
- Dr. Reddy's Key Markets Remain Challenged Despite Sequential Margin Improvement by Morningstar
- Dr. Reddy's Key Markets Remain Challenged Despite Sequential Margin Improvement by Morningstar
- CMS faces important regulatory developments in 2018. by Morningstar
- Defying Our Bearish Thesis, Silicon Valley Bank Continues to Perform by Morningstar
- Stronger flows and market gains helped lift Federated's AUM higher during 2017. by Morningstar
- The Protectionism Wave Hits a Wall: USITC Rules Against Boeing by Morningstar
- Weekly Update: AIT, LANC, MIDD, NDSN, POL, SMG, THO by Great Lakes Review, a division of Wellington Shields & Co. LLC
- Telia Reported 4Q Results In Line With Our Expectations; Maintaining FVE, Shares Fairly Valued by Morningstar
- Power management powerhouse Eaton will benefit from growing demand for energy efficiency. by Morningstar
- Qiagen's 3Q Meets Our Expectations by Morningstar
- Wynn Resort Shares Down on Misconduct Allegations; No Change to Moat or FVE at This Time by Morningstar
- Baer's international expansion increases its long-term growth potential. by Morningstar
- Despite strong execution and premiumization efforts, Pinnacle faces intense competition. by Morningstar
- Deutsche Boerse's renewed focus on growth and costs should drive revenue and profitability. by Morningstar
- Ceylon Cold Stores: Cut target price on bleak consumer outlook and further retail delays by Tellimer
- CSCI Morning News Circular - 20180129 by CSCI
- MOSL: SHRIRAM TRANSPORT FINANCE (Buy)-Strong quarter-Growth surprises positively by Motilal Oswal
- MOSL: DR REDDY’ S LABS (Neutral)-Revenue largely in-line-key product approvals delayed by Motilal Oswal
- Stronger Derivatives Turnover Underpins Singapore Exchange's 2Q Result by Morningstar
- MOSL: SHRIRAM CITY UNION FINANCE (Buy)-Investing in 2W financing business-Other segments stable by Motilal Oswal
- MOSL: MARUTI SUZUKI (Buy)-Operating performance in-line-lower other income dents PAT by Motilal Oswal
- MOSL: BIOCON (Neutral)-In-line results-key approvals awaited in CY18 by Motilal Oswal
- MOSL: MPHASIS (Neutral)-Above estimate, but lopsided-profitability beat led by SGA pruning and one-time settlement by Motilal Oswal
- MOSL: Morning India (29/January/18): 1. Maruti Suzuki; 2. Avenue Supermarts; 3. Pidilite Inds; 4. Dr Reddy's Labs; 5. Biocon; 6. Container Corpn; 7. Shriram Transport Fin; 8. Divi's Lab; 9. LIC Housing Fin; 10. by Motilal Oswal